Omixon at the EFI Annual Meeting 2019

30/04/2019

Omixon announces today that Holotype HLA and other Omixon products will be featured in 12 poster presentations at the annual meeting of the European Federation for Immunogenetics (EFI) in Lisbon, Portugal. Among the major scientific events, Omixon’s Lunch Symposium on Thursday will focus on HLA typing for disease associations using...

New Approaches in HLA Matching – PIRCHE

29/04/2019

Authors: Libor Kolesar, Matthias Niemann, Efi Melista INTRODUCTION In the previous blog post we talked about a hot topic in the HLA community right now which is the one of epitope-based matching. We discussed one of the methodologies that are commonly used, HLA Matchmaker, and this time we will be...

Join Omixon for our Lunchtime Symposium at EFI 2019!

16/04/2019

Omixon is pleased to announce our Symposium at the 2019 EFI Meeting in Lisbon, Portugal which will focus on HLA typing in disease associations using NGS, featuring two guest speakers, Dr. Mohamed Jahromi (Dasman Diabetes Institute, Kuwait) and Professor Mehdi Tafti (University of Lausanne, Switzerland). Additionally, Omixon’s Head of Product, Efi Melista will...

Omixon CSR Activities – Interview with Zoltan Simon, COO

28/03/2019

The following interview is part of the Omixon interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers at Omixon. We asked Zoltan Simon, the COO of Omixon to share his thoughts about the company’s Corporate Social Responsibility (CSR) related activities and to outline the company’s...

New Approaches in HLA Matching – HLA Matchmaker

27/03/2019

Written by Dr. Libor Kolesár (Senior Field Applications Scientist, Omixon) Introduction Most transplant laboratories’ protocols for donor/patient matching are based on the number of mismatches between patient and donor HLA alleles/antigens. The fewer mismatches between two individuals, the better. In solid organ transplantation (SOT) minimum matching refers to matching...